Table 1 Baseline clinical characteristics of patients with an LVAD
No | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
Gender | Male | Male | Male | Male |
Age (years) | 40s | 10s | 50s | 40s |
LVAD device | HM II | HM II | HM II | HM II |
Preimplant device strategy | BTT | BTT | BTT | BTT |
Period of LVAD@home system (days) | 581 | 643 | 464 | 400 |
PT-INR results of CoaguCheck® XS (times) | 53 | 77 | 58 | 51 |
Co-administration of any antiplatelet agent | Aspirin | Aspirin | Aspirin | Aspirin |
Target PT-INR | 1.8–2.6 | 1.8–2.6 | 1.8–2.6 | 1.8–2.6 →2.5–3.5 |